Xbrane Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Xbrane Biopharma's estimated annual revenue is currently $18M per year.
- Xbrane Biopharma's estimated revenue per employee is $155,000
Employee Data
- Xbrane Biopharma has 116 Employees.
- Xbrane Biopharma grew their employee count by -6% last year.
Xbrane Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO & Head Biosimilars | Reveal Email/Phone |
2 | Head Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
3 | Head Clinical Affairs | Reveal Email/Phone |
4 | Head Downstream Process Development | Reveal Email/Phone |
5 | Senior Manufacturing Manager | Reveal Email/Phone |
6 | Senior Manufacturing Manager | Reveal Email/Phone |
7 | Clinical Operations Manager | Reveal Email/Phone |
8 | Principal Scientist Upstream Process Development | Reveal Email/Phone |
9 | Group financial controller | Reveal Email/Phone |
Xbrane Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Xbrane Biopharma?
Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. We enable global health equality by bringing affordable drugs to treat underserved people suffering from critical diseases. Xbrane posses world leading expertise in developing true generics for injectable controlled release drugs and proprietary high-yield protein expression technology.
keywords:N/A
N/A
Total Funding
116
Number of Employees
$18M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xbrane Biopharma News
Xbrane Biopharma is not a large company by global standards. It has a market capitalization of kr2.2b, which means it wouldn't have the...
Debiopharm Group; Ipsen; Xbrane Biopharma; Chengdu Tiantaishan Pharmaceutical; Arbor Pharmaceuticals; Ferring. Triptorelin Drug Market Breakdown by Type: 3.75...
Xbrane Biopharma has taken a key step on its journey to begin generating cash from operations by early 2024 at the latest, after its Xlucane...
Other Companies in Solna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.4M | 128 | 2% | N/A |
#2 | $15.4M | 128 | 2% | N/A |
#3 | $15.4M | 128 | 2% | N/A |
#4 | $19M | 131 | -5% | N/A |
#5 | $38.6M | 133 | 7% | N/A |